|
|
|
Insider
Information: |
14159, L.p. |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
1,167,526 |
|
Indirect Shares
|
135,452,076 |
|
|
Direct
Value |
$60,591,954 |
|
|
Indirect Value
|
$19,110,676,958 |
|
|
Total
Shares |
136,619,602 |
|
|
Total
Value |
$19,171,268,913 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2014-03-06 |
1,020 |
2014-03-06 |
2,619,123 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-07-19 |
360,231 |
2013-05-23 |
489,039 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-07-26 |
247,063 |
2016-05-17 |
491,774 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
Director, 10% Owner |
2013-01-18 |
346,725 |
2016-08-10 |
22,789,815 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2014-12-09 |
107,504 |
2014-12-10 |
24,995,342 |
Premium* |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2013-06-11 |
104,983 |
2013-06-11 |
414,249 |
Premium* |
|
Beigene Ltd |
BGNE |
Director, 10% Owner |
2016-02-08 |
0 |
2016-11-18 |
83,652,734 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2013-12-04 |
4 |
B |
$42.65 |
$11,675,184 |
I/I |
270,795 |
342,243 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2013-12-05 |
4 |
B |
$43.98 |
$16,089,489 |
I/I |
365,676 |
351,151 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2013-01-04 |
4 |
B |
$47.53 |
$40,862,492 |
I/I |
859,720 |
176,920 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2013-09-25 |
4 |
B |
$56.63 |
$59,461,500 |
I/I |
1,050,000 |
202,583 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2014-03-06 |
4 |
B |
$105.75 |
$39,656,250 |
I/I |
375,000 |
211,614 |
2.25 |
- |
|
55 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|